ID

31183

Descripción

Study ID: 104505 Clinical Study ID: BEX104505 Study Title: Phase II Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00950755 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin Please record all concomitant medications and transfusions from the time of study entry through the Week 13 visit. Include study-required medications (i.e. Lugol's solution or potassium iodide, paracetamol, and diphenhydramine).

Palabras clave

  1. 25/7/18 25/7/18 -
Titular de derechos de autor

see clinicaltrials.gov

Subido en

25 de julio de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Iodine 131 B1 Antibody for B-Cell Lymphomas NCT00950755

Concomitant Medications & Transfusions

Administrative Data
Descripción

Administrative Data

Alias
UMLS CUI-1
C1320722
Site Number
Descripción

Site number

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0018704
UMLS CUI [1,2]
C0600091
Patient Number
Descripción

Patient Number

Tipo de datos

text

Alias
UMLS CUI [1]
C1830427
Patient Initials
Descripción

Patient Initials

Tipo de datos

text

Alias
UMLS CUI [1]
C2986440
Concomitant Medications; Concomitant Transfusions
Descripción

Concomitant Medications; Concomitant Transfusions

Alias
UMLS CUI-1
C2347852
Drug Name or Blood Product
Descripción

Concomitant Agent; Drug Name or Blood Product

Tipo de datos

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C2360065
UMLS CUI [1,3]
C0456388
Dose
Descripción

Concomitant Agent; Dose

Tipo de datos

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C3174092
Unit
Descripción

Concomitant Agent; Unit

Tipo de datos

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C1519795
Route
Descripción

Concomitant Agent; Route

Tipo de datos

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0013153
Frequency
Descripción

Concomitant Agent; Frequency

Tipo de datos

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C3476109
Start Date
Descripción

Concomitant Agent; Start Date

Tipo de datos

date

Alias
UMLS CUI [1]
C2826734
End Date
Descripción

Concomitant Agent; End Date

Tipo de datos

date

Alias
UMLS CUI [1]
C2826744

Similar models

Concomitant Medications & Transfusions

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Site number
Item
Site Number
text
C0018704 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Patient Number
Item
Patient Number
text
C1830427 (UMLS CUI [1])
Patient Initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
Item Group
Concomitant Medications; Concomitant Transfusions
C2347852 (UMLS CUI-1)
Concomitant Agent; Drug Name or Blood Product
Item
Drug Name or Blood Product
text
C2347852 (UMLS CUI [1,1])
C2360065 (UMLS CUI [1,2])
C0456388 (UMLS CUI [1,3])
Concomitant Agent; Dose
Item
Dose
text
C2347852 (UMLS CUI [1,1])
C3174092 (UMLS CUI [1,2])
Concomitant Agent; Unit
Item
Unit
text
C2347852 (UMLS CUI [1,1])
C1519795 (UMLS CUI [1,2])
Concomitant Agent; Route
Item
Route
text
C2347852 (UMLS CUI [1,1])
C0013153 (UMLS CUI [1,2])
Concomitant Agent; Frequency
Item
Frequency
text
C2347852 (UMLS CUI [1,1])
C3476109 (UMLS CUI [1,2])
Concomitant Agent; Start Date
Item
Start Date
date
C2826734 (UMLS CUI [1])
Concomitant Agent; End Date
Item
End Date
date
C2826744 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial